Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Up 1.4% – What’s Next?

Shares of Bayer Aktiengesellschaft (ETR:BAYNGet Free Report) were up 1.4% during mid-day trading on Monday . The stock traded as high as €19.90 ($20.95) and last traded at €19.80 ($20.84). Approximately 4,478,001 shares traded hands during trading, The stock had previously closed at €19.52 ($20.55).

Bayer Aktiengesellschaft Trading Up 0.6 %

The company has a debt-to-equity ratio of 129.94, a current ratio of 1.27 and a quick ratio of 0.72. The business’s 50-day moving average price is €25.80 and its two-hundred day moving average price is €26.78. The company has a market capitalization of $19.58 billion, a price-to-earnings ratio of -15.35, a P/E/G ratio of 36.39 and a beta of 0.97.

About Bayer Aktiengesellschaft

(Get Free Report)

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.

Featured Articles

Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.